International Biotechnology Trust plc
Share this pagePrint this page

Portfolio Analysis

31 May 2014

Summary

 

IBT Portfolio NAV (m)

187

Number of Portfolio Companies

90

Quoted Investments

64

Unquoted Investments

26

 

Quoted / Unquoted Split
NAV by Geography

Quoted

91%

United States / Canada

89%

Unquoted

9%

Europe

11%

Total

100% 

Total

100%

 

 

 

 

 

NAV by Subsector
NAV by Market Capitalisation

 

 

Therapeutics

76%

Large-Cap (>$10bn)

53%

Medical Devices

4%

Mid-Cap (>$1bn, <$10bn)

28%

Specialty Pharma

14%

Small-Cap (<$1bn)

10%

Life Sciences, Tools

6%

Unquoted

9%

Total100%

Total

100%

 

 

NAV by Development Phase
NAV by Portfolio Profitability

 

 

 

Marketed

64%

Profitable

64%

Regulatory

6%

Turning Profitable 2014

9%

Phase 3

16%

Unprofitable

27%

Phase 2

8%

Total

100%

Phase 1

2%

 

Other

4%

 

Total

100%